Cover Image

PAPERBACK
$47.95



View/Hide Left Panel

Verhoef P, Kok FJ, Kluijtmans LA, Blom HJ, Refsum H, Ueland PM, Kruyssen DA. 1997a. The 677C→T mutation in the methylene te trahydrofolate reductase gene: Associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 132:105–113.

Verhoef P, Rimm EB, Hunter DJ, Chen J, Willett WC, Kelsey K, Stampfer MJ. 1997b. Methylenetetrahydrofolate reductase polymorphism and risk of coronary heart disease: Results from health professionals study and meta-analysis. Am J Epid 145:307.

Verreault R, Chu J, Mandelson M, Shy K. 1989. A case-control study of diet and invasive cervical cancer. Int J Cancer 43:1050–1054.

Victor M, Lear AA. 1956. Subacute combined degeneration of the spinal cord. Current concepts of the disease process. Value of serum vitamin B12 determinations in clarifying some of the common clinical problems. Am J Med 20:896– 911 .

Vilter CF, Vilter RW, Spies TD. 1947. The treatment of pernicious and related anemias with synthetic folic acid. 1. Observations on the maintenance of a normal hematologic status and on the occurrence of combined system disease at the end of one year. J Lab Clin Med 32:262–273.

Volpe JJ. 1995. Neurology of the Newborn, 3rd ed. Philadelphia: WB Saunders.

Von der Porten AE, Gregory JF 3rd, Toth JP, Gerda JJ, Curry SH, Bailey LB. 1992. In vivo folate kinetics during chronic supplementation of human subjects with deuterium-labeled folic acid. J Nutr 122:1293–1299.

Wagley PF. 1948. Neurologic disturbances with folic acid therapy. N Engl J Med 238:11–15.

Wagner C. 1996. Symposium on the subcellular compartmentation of folate metabolism. J Nutr 126:1228S–1234S.

Wahlin A, Hill RD, Winblad B, Backman L. 1996. Effects of serum vitamin B12 and folate status on episodic memory performance in very old age: A population-based study. Psychol Aging 11:487–496.

Wald NJ. 1994. Folic acid and neural tube defects: The current evidence and implications for prevention. Ciba Found Symp 181:192–208.

Wald N, Sneddon J, Densem J, Frost C, Stone R. 1991. Prevention of neural tube defects: Results of the Medical Research Council vitamin study. Lancet 338:131– 137.

Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, Maeda N. 1995. Mice deficient in cystathionine beta-synthase: Animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 92:1585–1589.

Ward M, McNulty H, McPartlin J, Strain JJ, Weir DG, Scott JM. 1997. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. Q J Med 90:519–524.

Wei M-M, Bailey LB, Toth JP, Gregory JF 3rd. 1996. Bioavailability for humans of deuterium-labeled monoglutamyl and polyglutamyl folates is affected by selected foods. J Nutr 126:3100–3108.

Weir DG, McGing PG, Scott JM. 1985. Commentary: Folate metabolism, the enterohepatic circulation and alcohol. Biochem Pharmacol 34:1–7.

Weller M, Marini AM, Martin B, Paul SM. 1994. The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neurons. J Pharmacol Exp Ther 269:393–401.

Werler MM, Shapiro S, Mitchell AA. 1993. Periconceptional folic acid exposure and risk of occurrent neural tube defects. J Am Med Assoc 269:1257–1261.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement